REVIEW
Published on 13 Oct 2022
Clinical perspectives on the use of the GIP/GLP-1 receptor agonist tirzepatide for the treatment of type-2 diabetes and obesity
doi 10.3389/fendo.2022.1004044
- 28,438 views
- 44 citations
17k
Total downloads
76k
Total views and downloads
REVIEW
Published on 13 Oct 2022
REVIEW
Published on 22 Jul 2022
REVIEW
Published on 01 Mar 2022
REVIEW
Published on 25 Nov 2021